iloperidone
iloperidone is a pharmaceutical drug with 20 clinical trials. Currently 3 active trials ongoing. Historical success rate of 86.7%.
Success Metrics
Based on 13 completed trials
Phase Distribution
Phase Distribution
3
Early Stage
4
Mid Stage
11
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
81.3%
13 of 16 finished
18.8%
3 ended early
3
trials recruiting
20
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension
Randomized Withdrawal Study in Patients With Schizophrenia
Safety and Tolerability of Open-Labeled Iloperidone in Adolescents
Efficacy and Safety of Iloperidone Compared With Placebo and Active Control in Subjects With Acute Schizophrenia
Evaluation of Efficacy and Safety of Iloperidone in the Acute Treatment of Manic or Mixed Episodes Associated With Bipolar I Disorder
Clinical Trials (20)
Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension
Randomized Withdrawal Study in Patients With Schizophrenia
Safety and Tolerability of Open-Labeled Iloperidone in Adolescents
Efficacy and Safety of Iloperidone Compared With Placebo and Active Control in Subjects With Acute Schizophrenia
Evaluation of Efficacy and Safety of Iloperidone in the Acute Treatment of Manic or Mixed Episodes Associated With Bipolar I Disorder
A Study to Evaluate Iloperidone for the Treatment of Parkinson's Disease Psychosis
Relapse Prevention Study in Patients With Schizophrenia
A Study to Evaluate Iloperidone Long-acting Injection (LAI) for the Treatment of Schizophrenia
An Observational Drug Utilization Study of Asenapine in the United Kingdom (P08308)
Evaluating a New Iloperidone Titration Scheme in Bipolar I Disorder or Schizophrenia
Iloperidone for Symptoms of Arousal in Post Traumatic Stress Disorder (PTSD)
Family Intervention in Recent Onset Schizophrenia Treatment (FIRST)
Iloperidone in Mixed States of Bipolar Disorder
Iloperidone Augmentation of SSRIs for Patients With Major Depressive Disorder With Residual Anger and Irritability
Assessment and Comparison of Metabolic Changes in Non-psychotic Adults Taking Iloperidone or Olanzapine or Placebo
Assessing the Effects of Fanapt® on Social Cognition in Schizophrenia
Risperidone-controlled,Multicentre Clinical Trial of Iloperidone in Patients With Schizophrenia
Efficacy and Safety Study of Iloperidone Virus Risperidone to Treat Schizophrenia
Switching to Iloperidone From Other Antipsychotics in Schizophrenia
Single-dose Iloperidone Pharmacokinetics in Patients With Mild or Moderate Liver Disease, Compared to Healthy Volunteers
All 20 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 20